MONARCH: a Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Miricorilant in Adult Patients with Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Alkhouri et al. • 2025 • MASH-TAG 2025 Congress
Alkhouri et al. • 2025 • MASH-TAG 2025 Congress
© 2024 Corcept Therapeutics, Incorporated